NVST
Envista Holdings Corp · Healthcare · Medical - Instruments & Supplies
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | -2 | 135.18M | $3.46B | +8 | −10 |
| Q1 2026 | 112 | +2 | 125.88M | $3.08B | +10 | −9 |
| Q4 2025 | 111 | +1 | 135.55M | $2.86B | +3 | −1 |
| Q3 2025 | 20 | 0 | 79.00M | $1.61B | +1 | −2 |
| Q2 2025 | 18 | +2 | 64.07M | $1.25B | +2 | — |
| Q1 2025 | 13 | -2 | 25.86M | $445.80M | — | −2 |
| Q4 2024 | 15 | 0 | 32.49M | $626.68M | — | — |
| Q3 2024 | 14 | +1 | 30.02M | $593.21M | +1 | — |
| Q2 2024 | 13 | — | 24.10M | $400.73M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Harris Associates (Oakmark) ✦ | 10.78M | — | $179.23M | 0.3% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.82M | — | $46.98M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 2.82M | — | $46.98M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (passive) | 1.98M | — | $32.92M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Tweedy, Browne ✦ | 1.90M | — | $31.63M | 1.5% | n/c | 1 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 1.47M | — | $24.48M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 1.47M | — | $24.48M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 1.13M | — | $18.77M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 1.02M | — | $17.02M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 996.27K | — | $16.57M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 996.27K | — | $16.57M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 934.00K | — | $15.53M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 655.97K | — | $10.91M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 230.71K | — | $3.84M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 139.48K | — | $2.32M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 31.82K | — | $529,200 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 10 holders, 12.46M shares, $12.36M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 8.00K sh · $220,000
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology